Shares of PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $23.11, but opened at $24.05. PureTech Health shares last traded at $24.05, with a volume of 3,444 shares traded.
PureTech Health Stock Performance
The firm’s 50-day simple moving average is $27.93 and its 200 day simple moving average is $26.38.
Institutional Trading of PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. AWM Investment Company Inc. bought a new position in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is owned by hedge funds and other institutional investors.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- Canada Bond Market Holiday: How to Invest and Trade
- Qualcomm Stock Continues to Rise in the Face of Negative News
- Upcoming IPO Stock Lockup Period, Explained
- Top 3 Summer Stocks with Solid Growth Opportunities
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
